[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omniab Inc (OABI)

Omniab Inc (OABI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 696,406
  • Shares Outstanding, K 144,783
  • Annual Sales, $ 18,670 K
  • Annual Income, $ -64,780 K
  • EBIT $ -33 M
  • EBITDA $ -12 M
  • 60-Month Beta 0.45
  • Price/Sales 36.15
  • Price/Cash Flow N/A
  • Price/Book 2.62

Options Overview Details

View History
  • Implied Volatility 108.49% (+16.30%)
  • Historical Volatility 104.61%
  • IV Percentile 12%
  • IV Rank 3.48%
  • IV High 1,055.70% on 11/12/25
  • IV Low 74.29% on 05/20/26
  • Expected Move (DTE 22) 0.34 (7.07%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 114
  • Volume Avg (30-Day) 436
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 5,354
  • Open Int (30-Day) 2,164
  • Expected Range 4.47 to 5.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.12
  • Number of Estimates 2
  • High Estimate $-0.11
  • Low Estimate $-0.12
  • Prior Year $-0.14
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.90 +153.16%
on 07/31/26
4.93 -2.43%
on 08/26/26
+2.78 (+136.95%)
since 07/24/26
3-Month
1.90 +153.16%
on 07/31/26
4.93 -2.43%
on 08/26/26
+2.26 (+88.63%)
since 05/26/26
52-Week
1.30 +270.00%
on 11/05/25
4.93 -2.43%
on 08/26/26
+3.20 (+198.76%)
since 08/26/25

Most Recent Stories

More News
OmniAb to Participate in Upcoming Investor Conferences

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced management’s participation in the following...

OABI : 4.81 (+3.22%)
OmniAb Raises 2026 Financial Guidance

Increases Full Year 2026 Cash Outlook Following Recent Technology Licensing Activity

OABI : 4.81 (+3.22%)
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced a global collaboration and license agreement...

OABI : 4.81 (+3.22%)
OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

Raises Full Year 2026 Revenue and Cash Outlook Driven by Continued Business Momentum Conference Call to Begin Today at 4:30 p.m. ET

OABI : 4.81 (+3.22%)
VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

VERAXA Biotech (NASDAQ: VRXA) announced the advancement of its bispecific antibody-drug conjugate (“bsADC”) program, VXA-222, after reaching a key technical milestone in its collaboration with OmniAb (NASDAQ:...

VRXA : 1.6400 (-5.20%)
OABI : 4.81 (+3.22%)
OmniAb to Report Second Quarter 2026 Financial Results on August 6

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report...

OABI : 4.81 (+3.22%)
OmniAb Names Amechi Nwachuku Chief Operating Officer

OmniAb, Inc. (NASDAQ:OABI) , a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, announces that it has appointed Amechi Nwachuku...

OABI : 4.81 (+3.22%)
OmniAb Q1 Earnings Call Highlights

OmniAb (NASDAQ:OABI) reported first-quarter 2026 results that management characterized as a “very strong start to the year,” driven primarily by clinical progress across its partner portfolio and associated...

OABI : 4.81 (+3.22%)
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights

Conference Call Begins at 4:30 p.m. Eastern Time Today

OABI : 4.81 (+3.22%)
OmniAb to Participate in Three Upcoming Investor Conferences

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences over the coming weeks. ...

OABI : 4.81 (+3.22%)

Business Summary

OmniAb Inc. discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. OmniAb Inc., formerly known as Avista Public Acquisition Corp. II, is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 5.24
2nd Resistance Point 5.09
1st Resistance Point 4.95
Last Price 4.81
1st Support Level 4.65
2nd Support Level 4.50
3rd Support Level 4.36

See More

52-Week High 4.93
Last Price 4.81
Fibonacci 61.8% 3.54
Fibonacci 50% 3.11
Fibonacci 38.2% 2.69
52-Week Low 1.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.